Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23.63%6.7M | 12.03%6.1M | -3.60%5.53M | 14.26%23.45M | 7.28%6.85M | 4.08%5.42M | 21.30%5.44M | 29.08%5.74M | 41.26%20.52M | 23.87%6.38M |
| Operating revenue | 23.63%6.7M | 12.03%6.1M | -3.60%5.53M | 14.26%23.45M | 7.28%6.85M | 4.08%5.42M | 21.30%5.44M | 29.08%5.74M | 41.26%20.52M | 23.87%6.38M |
| Cost of revenue | 31.43%4.14M | 17.25%3.87M | -5.39%3.59M | 8.35%14.66M | 21.25%4.42M | -8.20%3.15M | -0.56%3.3M | 20.87%3.8M | 39.77%13.53M | 60.91%3.64M |
| Gross profit | 12.81%2.56M | 4.00%2.23M | -0.08%1.94M | 25.68%8.79M | -11.29%2.43M | 27.75%2.27M | 83.18%2.15M | 48.83%1.94M | 44.23%6.99M | -5.17%2.74M |
| Operating expense | 35.83%4.06M | -4.07%3.62M | -6.95%3.31M | -6.72%14.43M | -3.44%4.11M | -27.28%2.99M | 2.21%3.78M | 4.40%3.56M | 26.08%15.47M | 143.42%4.26M |
| Selling and administrative expenses | 44.99%3.22M | -3.08%2.81M | -1.80%2.57M | -9.54%10.67M | -7.65%2.93M | -31.11%2.22M | 2.04%2.9M | 2.40%2.62M | 14.54%11.8M | 1.01%3.17M |
| -Selling and marketing expense | 47.29%62.7K | 296.04%44.33K | 131.35%25.8K | 237.26%139.17K | 157.21%74.25K | 1,286.19%42.57K | 226.55%11.19K | 89.08%11.15K | 19.03%41.26K | 485.68%28.87K |
| -General and administrative expense | 44.94%3.15M | -4.24%2.77M | -2.37%2.55M | -10.41%10.53M | -9.17%2.86M | -32.37%2.18M | 1.77%2.89M | 2.20%2.61M | 14.52%11.76M | 0.25%3.14M |
| Depreciation amortization depletion | 8.57%840.59K | -7.78%795.89K | -20.78%744.27K | -9.05%3.29M | -25.58%715.98K | -12.68%774.27K | -6.70%863.01K | 10.97%939.54K | 10.40%3.62M | 5.92%962.09K |
| -Depreciation and amortization | 8.57%840.59K | -7.78%795.89K | -20.78%744.27K | -9.05%3.29M | -25.58%715.98K | -12.68%774.27K | -6.70%863.01K | 10.97%939.54K | 10.40%3.62M | 5.92%962.09K |
| Other taxes | 51.11%-66 | 99.03%-52 | ---3.76K | 414.88%277K | 2,661.43%282.5K | 66.42%-135 | 92.99%-5.36K | --0 | ---87.97K | ---11.03K |
| Other operating expenses | 114.31%730 | -16.58%12.03K | ---- | 33.91%190.79K | 36.19%183.94K | -418.02%-5.1K | 10,996.92%14.43K | -76.68%1.32K | 110.90%142.48K | 110.26%135.07K |
| Operating profit | -108.88%-1.5M | 14.69%-1.39M | 15.20%-1.37M | 33.46%-5.64M | -10.71%-1.68M | 69.28%-715.96K | 35.40%-1.63M | 23.17%-1.62M | -14.22%-8.48M | -233.42%-1.52M |
| Net non-operating interest income (expenses) | -38.69%-1.42M | -97.25%-1.61M | -101.84%-1.73M | -99.20%-4.26M | -368.09%-1.56M | -125.89%-1.02M | 60.01%-814.4K | -274.14%-855.52K | -146.33%-2.14M | 338.10%582.34K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Non-operating interest expense | 78.49%1.06M | 150.13%1.24M | 214.24%1.38M | 124.65%2.44M | 164.46%910.91K | 73.10%595.53K | 132.88%494.76K | 136.85%440.4K | 48.50%1.09M | 78.14%344.44K |
| Total other finance cost | -16.53%358.31K | 15.40%368.86K | -17.40%342.88K | 72.86%1.81M | 170.17%650.32K | 291.50%429.29K | -82.48%319.65K | 871.67%415.12K | 657.03%1.05M | -1,909.27%-926.78K |
| Other net income (expenses) | 396.38%95.29K | 245.54%33.76K | 202.89%2.53K | -2,195.85%-229.03K | -70.36%-167.43K | -153.52%-32.15K | -233.82%-23.2K | -122.54%-2.46K | 99.73%-9.98K | 26.57%-98.28K |
| Gain on sale of security | 396.38%95.29K | 245.54%33.76K | -0.08%-6.26K | -2,195.85%-229.03K | -1,795.51%-167.43K | -538.42%-32.15K | -474.90%-23.2K | -172.80%-6.26K | 52.64%-9.98K | -288.61%-8.83K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---- | 131.28%8.79K | ---- | ---- | -90.73%6.03K | -180.25%-8.95K | -71.19%3.8K | -232.83%-133.33K | -69.33%-222.78K |
| Income before tax | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Net income continuous operations | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Diluted earnings per share | 0.00%-0.02 | 6.67%-0.028 | 0.00%-0.03 | 0.00%-0.11 | -300.00%-0.04 | 33.33%-0.02 | 40.00%-0.03 | 0.00%-0.03 | 31.25%-0.11 | -150.00%-0.01 |
| Basic earnings per share | 0.00%-0.02 | 6.67%-0.028 | 0.00%-0.03 | 0.00%-0.11 | -300.00%-0.04 | 33.33%-0.02 | 40.00%-0.03 | 0.00%-0.03 | 31.25%-0.11 | -150.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.